Developments continue within the Lhasa Intermediates data sharing initiative enhancing risk assessments
- June 18, 2024
Lhasa Limited is delighted to announce the release of new data to the Vitic Intermediates database.
This pre-competitive data sharing initiative facilitates anonymous sharing of Ames mutagenicity results, for common intermediates and compounds containing functional groups of interest.
Driving confidence in decisions: Updates to the Lhasa Carcinogenicity Database
- June 12, 2024
Lhasa Limited is pleased to announce new software updates to the Lhasa Carcinogenicity Database (LCDB), a freely available source of long-term carcinogenicity data.
Lhasa Limited release Zeneth 10, now with prediction types: Streamlined nitrosamine risk assessment
- April 4, 2024
Lhasa Limited is pleased to announce the release of Zeneth 10.0.0, featuring multiple updates including differing prediction types: Structure-based or nitrosamine risk assessment.
Introducing In Vivo data to the Complex Nitrosamine data sharing initiative
- March 28, 2024
Lhasa Limited is thrilled to announce the 5th release of the Vitic Complex Nitrosamine database, which has been expanded to include, for the first time, in vivo genotoxicity data.
Lhasa Limited release Acrostic: A revolutionary read-across tool for assessing nitrosamine carcinogenicity
- March 13, 2024
Lhasa Limited is pleased to announce the release of Acrostic, a cutting-edge read-across tool designed to enhance decision-making in establishing acceptable intake (AI) limits for novel and untested nitrosamines.
Refining chemical safety assessments through data sharing
- March 12, 2024
Lhasa Limited is delighted to announce the release of new data to the Vitic Excipients database. Excipients, a pre-competitive data sharing initiative, facilitates the anonymous sharing of excipient and vehicle toxicity data, helping members streamline their risk assessments.
New data released to advance understanding of compound-specific acceptable exposure limits
- March 11, 2024
Lhasa Limited is thrilled to announce the release of new data to Vitic Acceptable Intake (AI) and Permitted Daily Exposure (PDE) database users.
Lhasa Limited launches Consult Lhasa to provide expert scientific risk assessments worldwide
- January 9, 2024
Lhasa Limited is proud to announce the launch of Consult Lhasa, a wholly owned Lhasa Limited subsidiary, dedicated to providing expert scientific risk assessments to the pharmaceutical industry.
Lhasa Limited unveils Mirabilis 4.2: A leap forward in customisation and control
- December 15, 2023
Lhasa Limited is delighted to announce the release of Mirabilis 4.2, providing members with advanced customisation options, and a more streamlined user experience.
Empowering industry progression through collaborative data sharing
- December 7, 2023
Lhasa Limited is delighted to announce the release of new data to its Vitic Aromatic Amines database users.
The Aromatic Amines data sharing initiative is a collaboration of pharmaceutical organisations sharing data from Ames mutagenicity assays for primary aromatic amines.